Resmed Inc
(RMD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 227,894 | 253,199 | 207,163 | 273,710 | 201,769 |
| Receivables | 686,264 | 672,271 | 620,483 | 575,950 | 508,580 |
| Inventories | 1,011,269 | 988,955 | 864,852 | 743,910 | 664,943 |
| TOTAL | $2,337,815 | $2,325,156 | $2,033,697 | $1,931,478 | $1,704,300 |
| Non-Current Assets | |||||
| PPE Net | 528,778 | 522,745 | 487,376 | 498,181 | 513,250 |
| Intangibles | 3,353,302 | 3,354,036 | 2,276,994 | 2,282,386 | 2,302,301 |
| Other Non-Current Assets | 493,984 | 474,167 | 379,493 | 383,808 | 385,413 |
| TOTAL | $4,376,064 | $4,350,948 | $3,143,863 | $3,164,375 | $3,200,964 |
| Total Assets | $6,713,879 | $6,676,104 | $5,177,560 | $5,095,853 | $4,905,264 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 161,896 | 196,003 | 181,485 | 159,245 | 149,797 |
| Accrued Expenses | 347,354 | 312,169 | 324,055 | 344,722 | 326,276 |
| TOTAL | $761,691 | $732,714 | $692,659 | $689,299 | $667,265 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,575,963 | 1,790,689 | 785,436 | 765,325 | 668,735 |
| Deferred Revenues | 141,043 | 133,909 | 108,195 | 108,667 | 112,449 |
| Other Non-Current Liabilities | 221,826 | 204,231 | 157,128 | 175,309 | 185,655 |
| TOTAL | $2,019,679 | $2,205,263 | $1,052,014 | $1,045,803 | $959,195 |
| Total Liabilities | $2,781,370 | $2,937,977 | $1,744,673 | $1,735,102 | $1,626,460 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 146,931 | 146,909 | 146,484 | 146,425 | 146,285 |
| Common Shares | 588 | 588 | 586 | 586 | 585 |
| Retained earnings | 4,088,057 | 3,920,197 | 3,759,783 | 3,613,736 | 3,480,163 |
| Other shareholders' equity | -262,133 | -270,424 | -406,384 | -313,003 | -224,397 |
| TOTAL | $3,932,509 | $3,738,127 | $3,432,887 | $3,360,751 | $3,278,804 |
| Total Liabilities And Equity | $6,713,879 | $6,676,104 | $5,177,560 | $5,095,853 | $4,905,264 |